CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS

Lobbying for ORCHARD THERAPEUTICS NORTH AMERICA · Health

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · House · Senate · $30,000.00 income · posted Jan 16, 2026

Lobbying activity 1

Health Issues

Metachromatic Leukodystrophy included on Recommended Uniform Screening Panel (RUSP) Metachromatic Leukodystrophy treatment

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.